Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
46000,,,2662331,[],CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
46001,,,2662339,[],CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
46002,,,2663961,[],CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
46003,,,2663969,[],CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
46004,,,2663977,[],CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
46005,,,2663985,[],CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
46006,,,2671974,[],CHEMBL1035433,Total body clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,821523,=,1,1,=,,CL,mL.min-1.kg-1,,2.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,2.8
46007,,,2671975,[],CHEMBL1035434,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,821523,=,1,1,=,,CL_renal,mL.min-1.kg-1,,2.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,2.3
46008,,,2674022,[],CHEMBL1026151,Antibacterial activity against Streptococcus pneumoniae HMC 3041 after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46009,,,2674026,[],CHEMBL1026150,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46010,,,2674030,[],CHEMBL1026149,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46011,,,2674036,[],CHEMBL1026148,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46012,,,2674041,[],CHEMBL1026147,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
46013,,,2674047,[],CHEMBL1026146,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46014,,,2674053,[],CHEMBL1026145,"Antibacterial activity against penicillin-, quinolone-resistant Streptococcus pneumoniae HMC 1541 harboring mutation in L4 protein by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46015,,,2674059,[],CHEMBL1026144,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46016,,,2674065,[],CHEMBL1026143,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46017,,,2674071,[],CHEMBL1026142,"Antibacterial activity against penicillin-, quinolone-resistant and macrolide-susceptible Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46018,,,2674077,[],CHEMBL1031971,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46019,,,2674083,[],CHEMBL1031970,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 441 expressing ermB by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46020,,,2674089,[],CHEMBL1031969,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
46021,,,2674095,[],CHEMBL1031968,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46022,,,2674101,[],CHEMBL1031967,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46023,,,2674107,[],CHEMBL1031966,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46024,,,2674113,[],CHEMBL1031965,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46025,,,2674119,[],CHEMBL1031964,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46026,,,2674124,[],CHEMBL1031142,"Antibacterial activity against Streptococcus pneumoniae HMC 1068 harboring E85K mutation in quinolone-resistant determining regions of GyrA gene, S79Y, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46027,,,2674130,[],CHEMBL1031141,"Antibacterial activity against Streptococcus pneumoniae HMC 1062 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46028,,,2674136,[],CHEMBL1031140,"Antibacterial activity against Streptococcus pneumoniae HMC 4026 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46029,,,2674142,[],CHEMBL1031139,"Antibacterial activity against Streptococcus pneumoniae HMC 2536 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46030,,,2674148,[],CHEMBL1031138,"Antibacterial activity against Streptococcus pneumoniae HMC 2527 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46031,,,2674154,[],CHEMBL1031137,"Antibacterial activity against Streptococcus pneumoniae HMC 1541 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46032,,,2674160,[],CHEMBL1031136,"Antibacterial activity against Streptococcus pneumoniae HMC 1156 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46033,,,2674166,[],CHEMBL1031135,"Antibacterial activity against Streptococcus pneumoniae HMC 1139 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46034,,,2674172,[],CHEMBL1026129,"Antibacterial activity against Streptococcus pneumoniae HMC 1078 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46035,,,2674178,[],CHEMBL1026128,Antibacterial activity against Streptococcus pneumoniae HMC 1077 harboring S81Y and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46036,,,2674184,[],CHEMBL1026127,"Antibacterial activity against Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46037,,,2674190,[],CHEMBL1026126,"Antibacterial activity against Streptococcus pneumoniae HMC 1072 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46038,,,2674196,[],CHEMBL1026125,"Antibacterial activity against Streptococcus pneumoniae HMC 1071 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and S79F, K137N mutation in QRDR of ParC gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46039,,,2674202,[],CHEMBL1026124,"Antibacterial activity against Streptococcus pneumoniae HMC 1059 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46040,,,2674208,[],CHEMBL1025290,"Antibacterial activity against Streptococcus pneumoniae HMC 1055 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46041,,,2674214,[],CHEMBL1025289,Antibacterial activity against Streptococcus pneumoniae HMC 5041 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46042,,,2674220,[],CHEMBL1025288,"Antibacterial activity against Streptococcus pneumoniae HMC 2538 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin, gatifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46043,,,2674226,[],CHEMBL1025287,"Antibacterial activity against Streptococcus pneumoniae HMC 1150 harboring S81C mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46044,,,2674232,[],CHEMBL1025286,"Antibacterial activity against Streptococcus pneumoniae HMC 1147 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46045,,,2674238,[],CHEMBL1025285,"Antibacterial activity against Streptococcus pneumoniae HMC 1146 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and D435N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46046,,,2674244,[],CHEMBL1025284,"Antibacterial activity against Streptococcus pneumoniae HMC 1076 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46047,,,2674250,[],CHEMBL1025283,"Antibacterial activity against Streptococcus pneumoniae HMC 1073 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46048,,,2674256,[],CHEMBL1025282,"Antibacterial activity against Streptococcus pneumoniae HMC 1070 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46049,,,2674262,[],CHEMBL1025281,"Antibacterial activity against Streptococcus pneumoniae HMC 1066 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46050,,,2674268,[],CHEMBL1025280,"Antibacterial activity against Streptococcus pneumoniae HMC 1060 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46051,,,2674927,[],CHEMBL1025279,"Antibacterial activity against Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
46052,,,2674933,[],CHEMBL1031123,"Antibacterial activity against Streptococcus pneumoniae HMC 1151 harboring D83N, K137N mutation in quinolone-resistant determining regions of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
46053,,,2674939,[],CHEMBL1031122,"Antibacterial activity against Streptococcus pneumoniae HMC 1149 harboring S81F and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
46054,,,2674947,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
46055,,,2674956,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
46056,,,2674965,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46057,,,2674974,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46058,,,2674983,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46059,,,2674992,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46060,,,2675001,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46061,,,2675010,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46062,,,2675019,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46063,,,2675028,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46064,,,2675037,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46065,,,2675046,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46066,,,2675055,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46067,,,2675065,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46068,,,2675080,[],CHEMBL1026154,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae HMC 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46069,,,2675086,[],CHEMBL1026155,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46070,,,2675091,[],CHEMBL1026156,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46071,,,2675097,[],CHEMBL1026974,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 41 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46072,,,2675103,[],CHEMBL1026975,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 42 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46073,,,2675109,[],CHEMBL1026976,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene after 22 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46074,,,2675115,[],CHEMBL1026977,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S79Y mutation in quinolone-resistant determining regions of ParC gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46075,,,2675121,[],CHEMBL1026978,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 28 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46076,,,2675127,[],CHEMBL1026979,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 36 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46077,,,2675133,[],CHEMBL1026980,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 49 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46078,,,2675139,[],CHEMBL1026981,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and I460V, D435N mutation in QRDR of ParE gene after 46 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46079,,,2675145,[],CHEMBL1029503,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring I460V mutation in QRDR of ParE gene after 41 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
46080,,,2675151,[],CHEMBL1031996,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F, E85K mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 27 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46081,,,2675157,[],CHEMBL1031999,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 38 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46082,,,2675165,[],CHEMBL1032774,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 44 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46083,,,2675171,[],CHEMBL1032778,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA after 46 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46084,,,2675176,[],CHEMBL1032783,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB after 28 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819150,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46085,,,2680866,[],CHEMBL1060597,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 46 harboring DNA gyrase A D87G mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.032
46086,,,2680867,[],CHEMBL1060589,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT61 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.064
46087,,,2680868,[],CHEMBL1061493,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG176 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.09,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.09
46088,,,2680869,[],CHEMBL1060588,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT29 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46089,,,2680870,[],CHEMBL1060590,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 102 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46090,,,2680871,[],CHEMBL1060598,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 50 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46091,,,2680872,[],CHEMBL1060602,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT118 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46092,,,2680873,[],CHEMBL1060604,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT144 harboring DNA gyrase A D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46093,,,2680874,[],CHEMBL1060605,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT145 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46094,,,2680875,[],CHEMBL1060608,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT3 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46095,,,2680876,[],CHEMBL1060610,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT15 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.094
46096,,,2680877,[],CHEMBL1060591,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 104 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46097,,,2680878,[],CHEMBL1060592,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 107 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46098,,,2680879,[],CHEMBL1060593,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate nar 108 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46099,,,2680880,[],CHEMBL1060594,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate ipt 2 harboring DNA gyrase A D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46100,,,2680881,[],CHEMBL1060596,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 45 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46101,,,2680882,[],CHEMBL1060599,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 51 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46102,,,2680883,[],CHEMBL1060600,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate ipt 32 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46103,,,2680884,[],CHEMBL1060601,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate ipt 33 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46104,,,2680885,[],CHEMBL1060603,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT142 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46105,,,2680886,[],CHEMBL1060607,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT2 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46106,,,2680887,[],CHEMBL1060612,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT37 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46107,,,2680888,[],CHEMBL1061475,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT40 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46108,,,2680889,[],CHEMBL1061476,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT42 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46109,,,2680890,[],CHEMBL1061477,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT47 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46110,,,2680891,[],CHEMBL1061478,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT48 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46111,,,2680892,[],CHEMBL1061479,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT49 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46112,,,2680893,[],CHEMBL1061480,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT54 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46113,,,2680894,[],CHEMBL1061481,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT60 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
46114,,,2680895,[],CHEMBL1061487,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG15 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46115,,,2680896,[],CHEMBL1061488,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG16 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46116,,,2680897,[],CHEMBL1061491,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG168 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46117,,,2680898,[],CHEMBL1061492,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG169 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46118,,,2680899,[],CHEMBL1061494,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG182 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46119,,,2680900,[],CHEMBL1061496,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG259 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46120,,,2680901,[],CHEMBL1061497,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate HTD 798 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.13
46121,,,2680902,[],CHEMBL1060583,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate D43 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46122,,,2680903,[],CHEMBL1060584,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate B111 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46123,,,2680904,[],CHEMBL1060585,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate E86 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46124,,,2680905,[],CHEMBL1060586,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate A102 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46125,,,2680906,[],CHEMBL1060587,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate C152 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46126,,,2680907,[],CHEMBL1060595,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 28 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46127,,,2680908,[],CHEMBL1061484,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG6 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46128,,,2680909,[],CHEMBL1061485,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG7 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46129,,,2680910,[],CHEMBL1061486,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG8 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46130,,,2680911,[],CHEMBL1061489,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG17 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46131,,,2680912,[],CHEMBL1061495,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG258 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46132,,,2680913,[],CHEMBL1061498,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate BL 21801 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46133,,,2680914,[],CHEMBL1061499,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate BL 21095 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46134,,,2680915,[],CHEMBL1061500,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate BL 3769 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.19
46135,,,2680916,[],CHEMBL1060609,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT9 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
46136,,,2680917,[],CHEMBL1060611,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT18 harboring DNA gyrase A S83F and D87G mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
46137,,,2680918,[],CHEMBL1061482,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG3 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
46138,,,2680919,[],CHEMBL1061483,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG5 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
46139,,,2680920,[],CHEMBL1061490,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG152 harboring DNA gyrase A S83F and D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823763,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
46140,,Active,2681400,[],CHEMBL1061505,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT76 harboring wild type DNA gyrase A assessed as decrease in bacterial population at 4 times MIC after 30 mins by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46141,,Active,2681401,[],CHEMBL1061506,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate HTD 798 harboring DNA gyrase A S83F mutation assessed as decrease in bacterial population at 4 times MIC after 30 mins by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46142,,Active,2681402,[],CHEMBL1061507,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT144 harboring DNA gyrase A D87G mutation assessed as decrease in bacterial population at 4 times MIC after 30 mins by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46143,,Active,2681403,[],CHEMBL1061508,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT76 harboring wild type DNA gyrase A assessed as complete cell killing at 4 times MIC after 6 hrs by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46144,,Active,2681404,[],CHEMBL1062270,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate HTD 798 harboring DNA gyrase A S83F mutation assessed as complete cell killing at 4 times MIC after 6 hrs by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46145,,Active,2681405,[],CHEMBL1062271,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT144 harboring DNA gyrase A D87G mutation assessed as complete cell killing at 4 times MIC after 6 hrs by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46146,,Active,2681406,[],CHEMBL1058785,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT18 harboring DNA gyrase A S83F and D87G mutation assessed as decrease in viable count at 8 times MIC after 4 hrs by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46147,,Active,2681407,[],CHEMBL1058786,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT18 harboring DNA gyrase A S83F and D87G mutation assessed as decrease in viable count at 16 times MIC after 4 hrs by time-kill analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,823763,,1,0,,,Activity,,,,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,Activity,,,,
46148,,,2711144,[],CHEMBL1053371,"Antibacterial activity against Escherichia coli 1608 containing gyrA L83, L87 mutants assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,826418,=,1,0,=,,Ratio,,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,5.0
46149,,,2711152,[],CHEMBL1053372,"Antibacterial activity against Escherichia coli 1596 containing gyrA L83 and parC I80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,826418,=,1,0,=,,Ratio,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.0
46150,,,2711162,[],CHEMBL1053374,"Antibacterial activity against Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1596 containing gyrA L83 and parC I80 mutants",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,826418,=,1,0,=,,Ratio,,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,9.0
46151,,,2711164,[],CHEMBL1053375,"Antibacterial activity against Escherichia coli SKM18 containing gyrA L83, Y87 and parC L80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,826418,=,1,0,=,,Ratio,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,2.0
46152,,,2727626,[],CHEMBL1055082,Inhibition of Mycobacterium leprae wild type DNA gyrase A2B2 assessed as DNA supercoiling inhibition,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,1,=,,IC50,ug.mL-1,,3.5,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,3.5
46153,,,2727627,[],CHEMBL1055083,Inhibition of Mycobacterium leprae DNA gyrase subunit A G89C mutant assessed as DNA supercoiling inhibition,B,Q57532,G89C,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,1,=,,IC50,ug.mL-1,,20.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,20.0
46154,,,2727628,[],CHEMBL1055084,Inhibition of Mycobacterium leprae DNA gyrase subunit A A91V mutant assessed as DNA supercoiling inhibition,B,Q57532,A91V,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,1,=,,IC50,ug.mL-1,,20.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,20.0
46155,,,2727629,[],CHEMBL1055085,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit B D205N mutant assessed as DNA supercoiling inhibition,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,1,=,,IC50,ug.mL-1,,4.5,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,4.5
46156,,,2727630,[],CHEMBL1055086,Inhibition of Mycobacterium leprae wild type DNA gyrase A2B2 assessed as formation of DNA cleavable complex,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,0,=,,CC25,ug ml-1,,0.3,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,0.3
46157,,Not Active,2727631,[],CHEMBL1055127,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit A G89A mutant assessed as formation of DNA cleavable complex,B,Q57532,G89A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,830013,,1,0,,,CC25,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,,,,
46158,,,2727632,[],CHEMBL1055128,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit A A91V mutant assessed as formation of DNA cleavable complex,B,Q57532,A91V,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,0,=,,CC25,ug ml-1,,4.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,4.0
46159,,,2727633,[],CHEMBL1055129,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit B D205N mutant assessed as formation of DNA cleavable complex,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830013,=,1,0,=,,CC25,ug ml-1,,0.3,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,0.3
46160,,,2727634,[],CHEMBL1055130,"Selectivity index, ratio of IC50 for Mycobacterium leprae DNA gyrase subunit A G89C mutant to IC50 for Mycobacterium leprae wild type DNA gyrase A2B2",B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,830013,=,1,0,=,,FC,,,3.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,FC,,,,3.0
46161,,,2727635,[],CHEMBL1055131,"Selectivity index, ratio of IC50 for Mycobacterium leprae DNA gyrase subunit A A91V mutant to IC50 for Mycobacterium leprae wild type DNA gyrase A2B2",B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,830013,=,1,0,=,,FC,,,5.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,FC,,,,5.0
46162,,,2727689,[],CHEMBL1055132,"Selectivity index, ratio of CC25 for Mycobacterium leprae DNA gyrase subunit A A91V mutant to CC25 for Mycobacterium leprae wild type DNA gyrase A2B2 by DNA cleavage assay",B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,830013,=,1,0,=,,FC,,,12.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,FC,,,,12.0
46163,,,2914883,[],CHEMBL1050057,Inhibition of human HeLa cell proliferation,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,847468,=,1,1,=,,IC50,nM,,400000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,uM,UO_0000065,,400.0
46164,,Active,2929313,[],CHEMBL1053623,Inhibition of penicillin-sensitive Streptococcus pneumoniae R6 PBP2X preincubated for 1 hr before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid,B,,,BAO_0000375,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155224,J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,851425,,1,0,,,Activity,,,,CHEMBL1255138,Streptococcus pneumoniae R6,Penicillin-binding protein 2X,171101.0,,,Activity,,,,
46165,,Active,2929316,[],CHEMBL1053624,Inhibition of penicillin-resistant Streptococcus pneumoniae 5204 PBP2X preincubated for 4 hrs before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid,B,,,BAO_0000375,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155224,J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,851425,,1,0,,,Activity,,,,CHEMBL6188,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2x,170187.0,,,Activity,,,,
46166,,,2946605,[],CHEMBL1041438,Antimalarial activity against Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,849321,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,10.0
46167,,,2946608,[],CHEMBL1041439,Antimalarial activity against Plasmodium falciparum NF54,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,849321,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,10.0
46168,,,2978248,[],CHEMBL1043586,Fraction escaping gut-wall elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,0,=,,Fg,,,1.02,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fg,,,,1.02
46169,,,2978455,[],CHEMBL1043588,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,1,=,,Vdss,L.kg-1,,1.7,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,1.7
46170,,,2978533,[],CHEMBL1043583,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,1,=,,CL_renal,mL.min-1.kg-1,,2.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,2.3
46171,,,2979657,[],CHEMBL1043581,Total clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,1,=,,CL,mL.min-1.kg-1,,2.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,2.8
46172,,,2990136,[],CHEMBL1046150,Permeability at pH 6.5 by PAMPA method,A,,,BAO_0002808,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156784,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,863492,=,1,0,=,,permeability,10'-6 cm/s,,20.0,CHEMBL612558,,ADMET,,,,permeability,10'-6 cm/s,,,20.0
46173,,,2990169,[],CHEMBL1046151,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156784,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,863492,=,1,1,=,,F,%,,96.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,96.0
46174,,,2992113,[],CHEMBL1043582,Hepatic clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,1,=,,CL,mL.min-1.kg-1,,0.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,0.5
46175,,,2994648,[],CHEMBL1043580,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,1,=,,Fu,,,0.8,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.8
46176,,,2996178,[],CHEMBL1043584,Oral bioavailability in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,0,=,,F_fraction,,,0.96,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F_fraction,,,,0.96
46177,,,2996184,[],CHEMBL1043585,Fraction absorbed in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,0,=,,Fa,,,0.96,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fa,,,,0.96
46178,,,2996292,[],CHEMBL1043587,Fraction escaping hepatic elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,861576,=,1,0,=,,Fh,,,0.98,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fh,,,,0.98
46179,,,3070512,[],CHEMBL1066048,Antibacterial activity against Staphylococcus aureus FDA 209-P after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
46180,,,3070525,[],CHEMBL1066049,Antibacterial activity against Staphylococcus epidermidis 56500 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
46181,,,3070538,[],CHEMBL1066050,Antibacterial activity against Streptococcus pneumoniae J-24 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.2
46182,,,3070551,[],CHEMBL1066051,Antibacterial activity against Streptococcus pyogenes G-36 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
46183,,,3070564,[],CHEMBL1066052,Antibacterial activity against Streptococcus mitis IID685 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.2
46184,,,3070577,[],CHEMBL1066053,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.39
46185,,,3071171,[],CHEMBL1044210,Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Micromolar,874688,=,1,0,=,,Activity,uM,,5.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,uM,UO_0000064,,5.06
46186,,,3071172,[],CHEMBL1044211,Antibacterial activity against Bacillus subtilis after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Micromolar,874688,=,1,0,=,,Activity,uM,,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,uM,UO_0000064,,4.0
46187,,,3071173,[],CHEMBL1044212,Antibacterial activity against Serratia marcescens after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Micromolar,874688,=,1,0,=,,Activity,uM,,2.93,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,uM,UO_0000064,,2.93
46188,,,3071174,[],CHEMBL1044213,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Micromolar,874688,=,1,0,=,,Activity,uM,,1.01,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,uM,UO_0000064,,1.01
46189,,,3071175,[],CHEMBL1044214,Antibacterial activity against Escherichia coli after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Micromolar,874688,=,1,0,=,,Activity,uM,,2.93,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,uM,UO_0000064,,2.93
46190,,,3071602,[],CHEMBL1066054,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
46191,,,3071615,[],CHEMBL1066055,Antibacterial activity against Klebsiella pneumoniae type 2 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
46192,,,3071628,[],CHEMBL1066056,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
46193,,,3071685,[],CHEMBL1066703,Inhibition of Staphylococcus aureus wild type DNA topoisomerase 4,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,IC50,ug.mL-1,,1.85,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,1.85
46194,,,3071687,[],CHEMBL1066706,Inhibition of Staphylococcus aureus wild type DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,IC50,ug.mL-1,,3.22,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,3.22
46195,,,3071694,[],CHEMBL1066705,Selectivity ratio of IC50 for Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant to IC50 for Staphylococcus aureus wild type DNA topoisomerase 4,B,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,875129,=,1,0,=,,Ratio IC50,,,12.16,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,12.16
46196,,,3071703,[],CHEMBL1066704,Inhibition of Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,IC50,ug.mL-1,,22.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,22.5
46197,,,3071707,[],CHEMBL1066708,Selectivity ratio of IC50 for Staphylococcus aureus DNA gyrase Ser84Leu mutant to IC50 for Staphylococcus aureus wild type DNA gyrase,B,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,875129,=,1,0,=,,Ratio IC50,,,89.1,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,89.1
46198,,,3071709,[],CHEMBL1066707,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,IC50,ug.mL-1,,287.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,ug ml-1,UO_0000274,,287.0
46199,,,3071718,[],CHEMBL1066065,"Antibacterial activity against ciprofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
46200,,,3071725,[],CHEMBL1066065,"Antibacterial activity against ciprofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
46201,,,3071732,[],CHEMBL1066700,Antibacterial activity against penicillin-intermediate resistant Streptococcus pneumoniae after 18 hrs by twofold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46202,,,3071739,[],CHEMBL1066700,Antibacterial activity against penicillin-intermediate resistant Streptococcus pneumoniae after 18 hrs by twofold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46203,,,3071746,[],CHEMBL1066701,Antibacterial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by twofold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,16.0
46204,,,3071753,[],CHEMBL1066701,Antibacterial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by twofold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,32.0
46205,,,3071760,[],CHEMBL1066702,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 18 hrs by twofold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,4.0
46206,,,3071767,[],CHEMBL1066702,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 18 hrs by twofold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875129,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,32.0
46207,,,3216143,[],CHEMBL1100460,"Dissociation constant, pKa of the compound",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,898523,=,1,0,=,,pKa,,,6.0,CHEMBL2362975,,No relevant target,,,,pKa,,,,6.0
46208,,,3217370,[],CHEMBL1100461,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,898523,=,1,0,=,,logFu,,,0.8,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,logFu,,,,0.8
46209,,,3217491,[],CHEMBL1100462,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,898523,=,1,1,=,,Vdss,L.kg-1,,1.75,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,1.75
46210,,,3385323,[],CHEMBL1221038,Antibacterial activity against Stenotrophomonas maltophilia D457 containing chromosomally encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930246,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.25
46211,,,3385324,[],CHEMBL1221039,Antibacterial activity against Stenotrophomonas maltophilia MBS108 containing both chromosomally and plasmid encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930246,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.75
46212,,,3385325,[],CHEMBL1221040,Antibacterial activity against Stenotrophomonas maltophilia MBS109 containing chromosomally encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930246,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.25
46213,,,3385326,[],CHEMBL1221041,Antibacterial activity against Stenotrophomonas maltophilia MBS82 deficient in Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930246,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.125
46214,,,3385327,[],CHEMBL1221042,Antibacterial activity against Stenotrophomonas maltophilia MBS101 containing plasmid encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930246,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.75
46215,,,3385328,[],CHEMBL1221043,Antibacterial activity against Stenotrophomonas maltophilia MBS100 deficient in Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930246,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.125
46216,,,3475515,[],CHEMBL1265807,"Antimicrobial activity against Streptococcus sp. 'group B' isolate 16 harboring gyrA Ser81Leu mutant, parC Ser79Tyr mutant and parE Ileu495Leu mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255331,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960107,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,8.0
46217,,,3475516,[],CHEMBL1265808,"Antimicrobial activity against Streptococcus sp. 'group B' isolate 9 harboring gyrA Ser81Leu mutant, parC Ser79Tyr mutant and parE Ileu495Leu mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255331,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960107,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,4.0
46218,,,3475517,[],CHEMBL1265809,"Antimicrobial activity against Streptococcus sp. 'group B' isolate 1 harboring gyrA Glu85Lys mutant, parC Ser79Tyr mutant and parE Ileu495Leu mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255331,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960107,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,4.0
46219,,,3494212,[],CHEMBL1262965,Antibacterial activity against Streptococcus pneumoniae assessed as susceptible isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255272,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,961050,=,1,0,=,,Activity,%,,98.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,98.7
46220,,,3494217,[],CHEMBL1262966,Antibacterial activity against Streptococcus pneumoniae assessed as resistant isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255272,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,961050,=,1,0,=,,Activity,%,,0.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.7
46221,,,3494224,[],CHEMBL1262967,Antibacterial activity against Streptococcus pneumoniae by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255272,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961050,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.25
46222,,,3494246,[],CHEMBL1262967,Antibacterial activity against Streptococcus pneumoniae by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255272,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961050,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.25
46223,,,3494262,[],CHEMBL1262967,Antibacterial activity against Streptococcus pneumoniae by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255272,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961050,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.12
46224,,,3496163,[],CHEMBL1263980,Antimicrobial activity against Mycobacterium tuberculosis H37Rv at assessed as growth inhibition at 10 mg/kg following 24 days oxygen depletion by Wayne method relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255311,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,959969,=,1,0,=,,Activity,%,,41.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,%,UO_0000187,,41.0
46225,,,3496423,[],CHEMBL1263723,Antimicrobial activity against Nocardia brasiliensis HUJEG-1 by broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255322,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959970,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,,MIC,ug ml-1,UO_0000274,,0.25
46226,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3496425,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1263719,"Cmax in BALB/c mouse serum at 100 mg/kg, sc TID for 4 weeks by HPLC method",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255322,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,959970,=,1,1,=,,Cmax,nM,,47948.85,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,18.0
46227,,Active,3496430,[],CHEMBL1263721,"Antimicrobial activity against Nocardia brasiliensis HUJEG-1 infected in BALB/c mouse assessed as decrease in number of lesions on foot-pad at 100 mg/kg, sc TID for 4 weeks",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255322,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,959970,,1,0,,,Activity,,,,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,,Activity,,,,
46228,,,3497169,[],CHEMBL1264054,Antimycobacterial activity against Mycobacterium abscessus after 3 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,8.0
46229,,,3514440,[],CHEMBL1264046,Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis after 21 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,0.125
46230,,,3514445,[],CHEMBL1264047,Antimycobacterial activity against quinolone-resistant multidrug-resistant Mycobacterium tuberculosis after 21 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,1.0
46231,,,3514450,[],CHEMBL1264048,Antimycobacterial activity against Mycobacterium kansasii after 7 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC50,ug ml-1,UO_0000274,,0.125
46232,,,3514455,[],CHEMBL1264049,Antimycobacterial activity against Mycobacterium fortuitum after 3 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC50,ug ml-1,UO_0000274,,0.125
46233,,,3514460,[],CHEMBL1264050,Antimycobacterial activity against Mycobacterium avium serovar 4 after 14 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC50,ug ml-1,UO_0000274,,2.0
46234,,,3514465,[],CHEMBL1264051,Antimycobacterial activity against Mycobacterium avium serovar 8 after 14 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC50,ug ml-1,UO_0000274,,2.0
46235,,,3514470,[],CHEMBL1264052,Antimycobacterial activity against Mycobacterium intracellular serovar 16 after 21 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC50,ug ml-1,UO_0000274,,4.0
46236,,,3514475,[],CHEMBL1264053,Antimycobacterial activity against Mycobacterium chelonae after 3 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC50,ug ml-1,UO_0000274,,16.0
46237,,,3514480,[],CHEMBL1264054,Antimycobacterial activity against Mycobacterium abscessus after 3 days by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC50,ug ml-1,UO_0000274,,32.0
46238,,,3514485,[],CHEMBL1264046,Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis after 21 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.25
46239,,,3514490,[],CHEMBL1264047,Antimycobacterial activity against quinolone-resistant multidrug-resistant Mycobacterium tuberculosis after 21 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,2.0
46240,,,3514495,[],CHEMBL1264048,Antimycobacterial activity against Mycobacterium kansasii after 7 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46241,,,3514500,[],CHEMBL1264049,Antimycobacterial activity against Mycobacterium fortuitum after 3 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC90,ug ml-1,UO_0000274,,0.25
46242,,,3514505,[],CHEMBL1264050,Antimycobacterial activity against Mycobacterium avium serovar 4 after 14 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC90,ug ml-1,UO_0000274,,8.0
46243,,,3514510,[],CHEMBL1264051,Antimycobacterial activity against Mycobacterium avium serovar 8 after 14 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC90,ug ml-1,UO_0000274,,8.0
46244,,,3514515,[],CHEMBL1264052,Antimycobacterial activity against Mycobacterium intracellular serovar 16 after 21 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC90,ug ml-1,UO_0000274,,16.0
46245,,,3514520,[],CHEMBL1264053,Antimycobacterial activity against Mycobacterium chelonae after 3 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC90,ug ml-1,UO_0000274,,32.0
46246,,,3514525,[],CHEMBL1264054,Antimycobacterial activity against Mycobacterium abscessus after 3 days by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC90,ug ml-1,UO_0000274,,64.0
46247,,,3514532,[],CHEMBL1264046,Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis after 21 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.06
46248,,,3514537,[],CHEMBL1264047,Antimycobacterial activity against quinolone-resistant multidrug-resistant Mycobacterium tuberculosis after 21 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
46249,,,3514542,[],CHEMBL1264048,Antimycobacterial activity against Mycobacterium kansasii after 7 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,ug ml-1,UO_0000274,,0.06
46250,,,3514547,[],CHEMBL1264049,Antimycobacterial activity against Mycobacterium fortuitum after 3 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,0.03
46251,,,3514552,[],CHEMBL1264050,Antimycobacterial activity against Mycobacterium avium serovar 4 after 14 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,1.0
46252,,,3514557,[],CHEMBL1264051,Antimycobacterial activity against Mycobacterium avium serovar 8 after 14 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,1.0
46253,,,3514562,[],CHEMBL1264052,Antimycobacterial activity against Mycobacterium intracellular serovar 16 after 21 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,1.0
46254,,,3514567,[],CHEMBL1264053,Antimycobacterial activity against Mycobacterium chelonae after 3 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1255490,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960177,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,4.0
46255,,,3534010,[],CHEMBL1280221,"Antimicrobial activity against Escherichia coli BicA expressing blaTEM-1, blaCTX-M-15 and qepA2 gene by disk diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970191,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
46256,,,3534037,[],CHEMBL1280222,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M plasmid carrying blaCTX-M-15 gene by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970191,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
46257,,,3534064,[],CHEMBL1280223,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M carrying blaCTX-M-15 and pQep plasmid carrying qepA2 gene by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970191,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
46258,,,3534091,[],CHEMBL1280224,Antimicrobial activity against azide-resistant Escherichia coli J53 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970191,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
46259,,,3534118,[],CHEMBL1280225,Antimicrobial activity against Escherichia coli TOP10 harboring pQep plasmid carrying qepA2 gene by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970191,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
46260,,,3534145,[],CHEMBL1280226,Antimicrobial activity against Escherichia coli TOP10 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970191,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
46261,,,3535364,[],CHEMBL1281176,Antimicrobial activity against Escherichia coli TOP10 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,<,1,1,<,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
46262,,,3535365,[],CHEMBL1281177,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr1 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
46263,,,3535366,[],CHEMBL1281178,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr2 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,<,1,1,<,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
46264,,,3535367,[],CHEMBL1281179,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr3 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
46265,,,3535368,[],CHEMBL1281180,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr4 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
46266,,,3535369,[],CHEMBL1281181,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr5 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,<,1,1,<,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
46267,,,3535370,[],CHEMBL1281182,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr6 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.064
46268,,,3535371,[],CHEMBL1281183,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr7 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.023
46269,,,3535372,[],CHEMBL1281184,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr8 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
46270,,,3535373,[],CHEMBL1281185,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr9 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
46271,,,3535374,[],CHEMBL1281186,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr10 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
46272,,,3535375,[],CHEMBL1281187,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr11 carrying Smqnr gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970038,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
46273,,,3541963,[],CHEMBL1283200,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus obtained from war-wounded patient assessed as susceptible isolates,F,,,BAO_0001103,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275597,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,970297,=,1,0,=,,Activity,%,,27.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,27.0
46274,,,3551877,[],CHEMBL1284664,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275259,Antimicrob Agents Chemother,2010.0,"{'bei': '13.39', 'le': '0.25', 'lle': '3.05', 'sei': '6.00'}",CHEMBL31,GATIFLOXACIN,CHEMBL31,5.03,0,http://www.openphacts.org/units/Nanomolar,970538,=,1,1,=,,IC50,nM,,9400.0,CHEMBL4165,Mycobacterium tuberculosis,DNA gyrase subunit A,1773.0,,,IC50,uM,UO_0000065,,9.4
46275,,,3551878,[],CHEMBL1284665,Inhibition of DNA supercoiling activitysof Mycobacterium tuberculosis DNA gyrase subunit A A90V mutant,B,P9WG47,A90V,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275259,Antimicrob Agents Chemother,2010.0,"{'bei': '12.13', 'le': '0.23', 'lle': '2.57', 'sei': '5.43'}",CHEMBL31,GATIFLOXACIN,CHEMBL31,4.55,0,http://www.openphacts.org/units/Nanomolar,970538,=,1,1,=,,IC50,nM,,28000.0,CHEMBL4165,Mycobacterium tuberculosis,DNA gyrase subunit A,1773.0,,,IC50,uM,UO_0000065,,28.0
46276,,,3551879,[],CHEMBL1284666,Inhibition of DNA supercoiling activity of Mycobacterium tuberculosis DNA gyrase subunit A D94G mutant,B,P9WG47,D94G,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275259,Antimicrob Agents Chemother,2010.0,"{'bei': '11.61', 'le': '0.22', 'lle': '2.38', 'sei': '5.20'}",CHEMBL31,GATIFLOXACIN,CHEMBL31,4.36,0,http://www.openphacts.org/units/Nanomolar,970538,=,1,1,=,,IC50,nM,,44000.0,CHEMBL4165,Mycobacterium tuberculosis,DNA gyrase subunit A,1773.0,,,IC50,uM,UO_0000065,,44.0
46277,,,3566358,[],CHEMBL1279704,"Clearance in tuberculosis patient at 400 mg/day, po administered for 7 days measured after 24 hrs by HPLC",A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969811,=,1,0,=,,CL,ml/min,,81.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min,,,81.0
46278,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3566362,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/day', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/day', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1279833,"Cmax in tuberculosis patient at 400 mg/day, po administered for 7 days by HPLC",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969811,=,1,1,=,,Cmax,nM,,10655.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,4.0
46279,,,3566363,[],CHEMBL1279834,"Tmax in tuberculosis patient at 400 mg/day, po administered for 7 days by HPLC",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,969811,=,1,1,=,,Tmax,hr,,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,2.0
46280,,,3566364,[],CHEMBL1279835,"Tmax in tuberculosis patient at 4.59 ug/ml, po administered for 7 days by HPLC",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,969811,=,1,1,=,,Tmax,hr,,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,8.0
46281,,,3566367,[],CHEMBL1279836,"Antimicrobial activity against Mycobacterium tuberculosis infected in patient at 400 mg/day, po administered for 7 days by HPLC",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969811,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
46282,,,3566368,[],CHEMBL1279837,"Ratio of fAUC in patient with tuberculosis at 400 mg/day, po administered for 7 days to MIC for Mycobacterium tuberculosis",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275405,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969811,=,1,0,=,,RatioAUC/MIC,,,179.77,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,179.77
46283,,,3568079,[],CHEMBL1278557,Antimicrobial activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6763 expressing gyrA Ser84Leu/Ser85Pro and grlA Ser80Phe/Glu84Lys mutants by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
46284,,,3568080,[],CHEMBL1278558,"Antimicrobial activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6764 expressing gyrA Ser84Leu, gyrB Asp437Glu norA T389C and grlA Ser80Phe/Glu84Lys mutants by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
46285,,,3568081,[],CHEMBL1278559,"Antimicrobial activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6765 expressing gyrA Ser84Leu, norA T389C and grlA Ser80Phe/Glu84Lys mutants by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
46286,,,3568082,[],CHEMBL1278560,Antimicrobial activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6766 expressing gyrA Glu84Lys and grlA Ser80Phe mutants by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
46287,,,3568083,[],CHEMBL1278561,Antimicrobial activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6767 expressing gyrA Glu84Lys and grlA Ser80Phe mutants by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
46288,,,3568084,[],CHEMBL1278562,Antimicrobial activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus JCSC 6768 expressing gyrA Glu84Lys and grlA Ser80Phe mutants by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
46289,,,3568085,[],CHEMBL1278563,Antimicrobial activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus JCSC 6769 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
46290,,,3568086,[],CHEMBL1278564,Antimicrobial activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus JCSC 6770 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
46291,,,3568087,[],CHEMBL1278565,Antimicrobial activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus JCSC 6822 harboring mutation in norA gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969659,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
46292,,Active,3568088,[],CHEMBL1278569,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 4 times MIC after 120 mins by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46293,,Active,3568089,[],CHEMBL1278570,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 8 times MIC after 120 mins by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46294,,Active,3568090,[],CHEMBL1278571,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 16 times MIC after 120 mins by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46295,,Not Active,3568091,[],CHEMBL1278566,Bactericidal activity against methicillin-resistant Staphylococcus aureus at 4 times MIC upto 60 mins by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46296,,Not Active,3568092,[],CHEMBL1278567,Bactericidal activity against methicillin-resistant Staphylococcus aureus at 8 times MIC upto 60 mins by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46297,,Not Active,3568093,[],CHEMBL1278568,Bactericidal activity against methicillin-resistant Staphylococcus aureus at 16 times MIC upto 60 mins by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46298,,Active,3568109,[],CHEMBL1278572,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 4 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46299,,Active,3568110,[],CHEMBL1278573,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 4 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46300,,Active,3568111,[],CHEMBL1278574,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 4 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46301,,Active,3568112,[],CHEMBL1278575,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 8 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46302,,Active,3568113,[],CHEMBL1278576,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 8 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46303,,Active,3568114,[],CHEMBL1278577,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 8 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46304,,Active,3568115,[],CHEMBL1278611,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 16 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46305,,Active,3568116,[],CHEMBL1278612,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 16 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46306,,Active,3568117,[],CHEMBL1278613,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 16 times MIC after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46307,,Active,3568118,[],CHEMBL1278614,Bactericidal activity against low level levofloxacin and methicillin-resistant Staphylococcus aureus at 2048 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46308,,Active,3568119,[],CHEMBL1278615,Bactericidal activity against high level levofloxacin and methicillin-resistant Staphylococcus aureus at 2048 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46309,,Active,3568120,[],CHEMBL1278616,Bactericidal activity against levofloxacin-sensitive and methicillin-resistant Staphylococcus aureus at 2048 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275457,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,969659,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
46310,,,3570521,[],CHEMBL1281214,Activity at Staphylococcus aureus wild-type DNA topoisomerase 4 subunit ParC,B,,,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969667,=,1,1,=,,CC50,nM,,220.0,CHEMBL612545,,Unchecked,,,,CC50,uM,UO_0000065,,0.22
46311,,,3570525,[],CHEMBL1281215,Activity at Staphylococcus aureus DNA topoisomerase 4 subunit ParC S80F mutant,B,,,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969667,=,1,1,=,,CC50,nM,,13000.0,CHEMBL612545,,Unchecked,,,,CC50,uM,UO_0000065,,13.0
46312,,,3570529,[],CHEMBL1281216,Activity at Staphylococcus aureus wild-type GyrA,B,,,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969667,=,1,1,=,,CC50,nM,,700.0,CHEMBL612545,,Unchecked,,,,CC50,uM,UO_0000065,,0.7
46313,,,3570533,[],CHEMBL1281217,Activity at Staphylococcus aureus wild-type GyrA S84L mutant,B,P20831,S84L,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969667,=,1,1,=,,CC50,nM,,18000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,CC50,uM,UO_0000065,,18.0
46314,,,3570537,[],CHEMBL1281218,Ratio of CC50 for wild-type Staphylococcus aureus GyrA to CC50 for wild-type Staphylococcus aureus ParC,B,,,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969667,=,1,1,=,,CC50,nM,,3200.0,CHEMBL612545,,Unchecked,,,,CC50,uM,UO_0000065,,3.2
46315,,,3570541,[],CHEMBL1281219,Ratio of CC50 for Staphylococcus aureus ParC S80F mutant to CC50 for wild-type Staphylococcus aureus ParC,B,,,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,969667,=,1,1,=,,CC50,nM,,59100.0,CHEMBL612545,,Unchecked,,,,CC50,uM,UO_0000065,,59.1
46316,,,3570567,[],CHEMBL1281361,Antimicrobial activity against Staphylococcus aureus CB190 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
46317,,,3570568,[],CHEMBL1281362,Antimicrobial activity against Staphylococcus aureus CB811 harboring quinolone-resistant gyrA S84L mutant gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
46318,,,3570569,[],CHEMBL1281363,Antimicrobial activity against Staphylococcus aureus CB808 harboring quinolone-resistant parC S80F mutant gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
46319,,,3570570,[],CHEMBL1281364,Antimicrobial activity against Staphylococcus aureus CB814 harboring fluoroquinolone-resistant gyrA S84L and parC S80F mutant genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
46320,,,3570571,[],CHEMBL1281365,Antimicrobial activity against Staphylococcus aureus CB370 harboring rifampin-resistant rpoB H481Y mutant gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
46321,,,3570572,[],CHEMBL1281366,Antimicrobial activity against Staphylococcus aureus CB812 harboring rpo B H481Y and gyrA S84L mutant genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
46322,,,3570573,[],CHEMBL1281367,Antimicrobial activity against Staphylococcus aureus CB812 harboring rpoB H481Y and gyrA S80F mutant genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
46323,,,3570574,[],CHEMBL1281368,"Antimicrobial activity against Staphylococcus aureus CB812 harboring rpoB H481Y, gyrA S84L and gyrA S80F mutant genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1275434,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969667,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
46324,,Active,3630061,[],CHEMBL1614538,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1900 (Counter Screen), 1677 (Project Summary), 1902 (Retest at Dose), 1662 (Primary HTS)]",F,,,BAO_0000188,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,5.96,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,EC50,nM,,1092.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,EC50,um,UO_0000065,,1.092
46325,,Active,3687890,[],CHEMBL1613910,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.5,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,Potency,nM,,31622.8,CHEMBL4159,Homo sapiens,Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,9606.0,,,Potency,um,UO_0000065,,31.6228
46326,,Active,3691438,[],CHEMBL1613910,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.5,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,31622.8,CHEMBL4159,Homo sapiens,Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,9606.0,,,Potency,um,UO_0000065,,31.6228
46327,,Inconclusive,3721226,[],CHEMBL1613914,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.6,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,25118.9,CHEMBL1293226,Homo sapiens,Lysine-specific demethylase 4D-like,9606.0,,,Potency,um,UO_0000065,,25.1189
46328,,Active,3767508,[],CHEMBL1613983,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",F,,,BAO_0000188,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,6.18,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,EC50,nM,,660.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,EC50,um,UO_0000065,,0.66
46329,,Active,3930642,[],CHEMBL1614364,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,"{'bei': '12.12', 'le': '0.23', 'lle': '2.57', 'sei': '5.43'}",CHEMBL31,GATIFLOXACIN,CHEMBL31,4.55,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,28183.8,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,um,UO_0000065,,28.1838
46330,,Inconclusive,4004976,[],CHEMBL1613769,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.6,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,25118.9,CHEMBL3563,Trypanosoma cruzi,Cruzipain,5693.0,,,Potency,um,UO_0000065,,25.1189
46331,,Active,4127654,[],CHEMBL1614455,"PUBCHEM_BIOASSAY: A Counter Screen to identiry small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1981, 1874 ]",F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,5.98,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,IC50,nM,,1050.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,1.05
46332,,Inconclusive,4174477,[],CHEMBL1614458,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.55,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,28183.8,CHEMBL3577,Homo sapiens,Aldehyde dehydrogenase 1A1,9606.0,,,Potency,um,UO_0000065,,28.1838
46333,,Active,4302732,[],CHEMBL1614127,"PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhimurium using a modified counterscreen. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1874 ]",F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,6.36,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,IC50,nM,,440.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,0.44
46334,,Active,4416580,[],CHEMBL1614183,PUBCHEM_BIOASSAY: High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv. (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1303580,<,7,1,<,,IC50,nM,,195.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,0.195
46335,,Inconclusive,4463658,[],CHEMBL1614240,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.7,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,19952.6,CHEMBL2903,Homo sapiens,Arachidonate 15-lipoxygenase,9606.0,,,Potency,um,UO_0000065,,19.9526
46336,,Active,4631405,[],CHEMBL1613791,"PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 2252, 1985 ]",F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,5.96,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,IC50,nM,,1100.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,1.1
46337,,Active,4682439,[],CHEMBL1613789,"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1981, 1874 ]",F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,6.24,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,IC50,nM,,580.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,0.58
46338,,Inconclusive,4800785,[],CHEMBL1614038,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.55,0,http://www.openphacts.org/units/Nanomolar,1158129,=,7,1,=,,Potency,nM,,28183.8,CHEMBL1293255,Homo sapiens,15-hydroxyprostaglandin dehydrogenase [NAD+],9606.0,,,Potency,um,UO_0000065,,28.1838
46339,,Active,4937613,[],CHEMBL1614064,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",F,,,BAO_0000188,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,6.17,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,EC50,nM,,668.0,CHEMBL1293228,Streptococcus pyogenes serotype M1,Streptokinase A,301447.0,,,EC50,um,UO_0000065,,0.668
46340,,Active,4992865,[],CHEMBL1614100,"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1864, 2252, 1985 ]",F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,6.54,0,http://www.openphacts.org/units/Nanomolar,1303580,=,7,1,=,,IC50,nM,,290.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,0.29
46341,,Active,5020167,[],CHEMBL1613892,PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi using a modified counterscreen. (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1303580,<,7,1,<,,IC50,nM,,230.0,CHEMBL612545,,Unchecked,,,,IC50,um,UO_0000065,,0.23
46342,,,5080688,[],CHEMBL1614672,Fraction unbound in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1310823,=,1,1,=,,Fu,,,0.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fu,,,,0.8
46343,,,5081370,[],CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1310823,=,1,1,=,,Vdss,L.kg-1,,1.7,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,1.7
46344,,,5081852,[],CHEMBL1614671,Clearance in human after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1310823,=,1,1,=,,CL,mL.min-1.kg-1,,2.8,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,2.8
46345,,,5082905,[],CHEMBL1614674,Half life in human after iv administration,A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,1310823,=,1,1,=,,T1/2,hr,,10.0,CHEMBL612558,,ADMET,,,,t1/2,h,UO_0000032,,10.0
46346,,,5082957,[],CHEMBL1614673,Mean residence time in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,1310823,=,1,1,=,,MRT,hr,,11.0,CHEMBL612558,,ADMET,,,,MRT,h,UO_0000032,,11.0
46347,,,5085947,[],CHEMBL1634884,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80, G84 and parE A458 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,30.0
46348,,,5085949,[],CHEMBL1634883,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80, G84 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
46349,,,5085950,[],CHEMBL1634882,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80 and parE A458 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
46350,,,5085951,[],CHEMBL1634881,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
46351,,,5085952,[],CHEMBL1634880,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC K84 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,30.0
46352,,,5085953,[],CHEMBL1634879,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
46353,,,5085954,[],CHEMBL1634878,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83,N87,gyrB V456, parC I80 and parE A458 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
46354,,,5085955,[],CHEMBL1634877,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80, K84 and parE D460 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
46355,,,5085956,[],CHEMBL1634876,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, gyrB T471 and parC I80, G84 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
46356,,,5085957,[],CHEMBL1634875,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC R80, V84 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
46357,,,5085958,[],CHEMBL1634874,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80, G84 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
46358,,,5085959,[],CHEMBL1634873,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE A548 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
46359,,,5085960,[],CHEMBL1634872,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE M464 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
46360,,,5085961,[],CHEMBL1634870,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC K84 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,30.0
46361,,,5085962,[],CHEMBL1634871,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
46362,,,5085963,[],CHEMBL1634869,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 mutant gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
46363,,,5085964,[],CHEMBL1634866,Antimicrobial activity against Escherichia coli K-12 harboring gyrA A83 mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.094
46364,,,5085965,[],CHEMBL1634868,Antimicrobial activity against Escherichia coli K-12 harboring parE A458 mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
46365,,,5085967,[],CHEMBL1634867,Antimicrobial activity against Escherichia coli K-12 harboring by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313901,=,1,1,=,,MIC,ug.mL-1,,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.007
46366,,,5085991,[],CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313905,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
46367,,,5085996,[],CHEMBL1634885,Antimicrobial activity against Escherichia coli ATCC 25922 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313905,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
46368,,,5085998,[],CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313905,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
46369,,,5085999,[],CHEMBL1634887,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313905,=,1,1,=,,MIC,ug.mL-1,,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,23.0
46370,,,5086000,[],CHEMBL1634888,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313905,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
46371,,,5140703,[],CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46372,,,5140717,[],CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
46373,,,5140731,[],CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
46374,,,5140747,[],CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46375,,,5140762,[],CHEMBL1666068,Antimicrobial activity against Streptococcus pneumoniae 1 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46376,,,5140777,[],CHEMBL1666069,Antimicrobial activity against Streptococcus pneumoniae 2 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46377,,,5140792,[],CHEMBL1666070,Antimicrobial activity against Streptococcus pneumoniae 3 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46378,,,5140807,[],CHEMBL1666071,Antimicrobial activity against Streptococcus pneumoniae 4 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46379,,,5140822,[],CHEMBL1666072,Antimicrobial activity against Streptococcus pneumoniae 5 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46380,,,5140837,[],CHEMBL1666073,Antimicrobial activity against Streptococcus pneumoniae 6 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46381,,,5140852,[],CHEMBL1666074,Antimicrobial activity against Streptococcus pneumoniae 7 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46382,,,5140867,[],CHEMBL1666075,Antimicrobial activity against Streptococcus pneumoniae 8 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46383,,,5140882,[],CHEMBL1666076,Antimicrobial activity against Streptococcus pneumoniae 9 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46384,,,5140897,[],CHEMBL1666077,Antimicrobial activity against Streptococcus pneumoniae 10 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46385,,,5140912,[],CHEMBL1666078,Antimicrobial activity against Streptococcus pneumoniae 11 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46386,,,5141982,[],CHEMBL1666079,Antimicrobial activity against Streptococcus pneumoniae 12 by time-kill analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46387,,,5141998,[],CHEMBL1666080,Antimicrobial activity against Streptococcus pneumoniae isolate 24 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46388,,,5142013,[],CHEMBL1666081,Antimicrobial activity against Streptococcus pneumoniae isolate 33 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46389,,,5142028,[],CHEMBL1666082,Antimicrobial activity against Streptococcus pneumoniae isolate 37 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46390,,,5142043,[],CHEMBL1666083,Antimicrobial activity against Streptococcus pneumoniae isolate 1055 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
46391,,,5142061,[],CHEMBL1666229,Antimicrobial activity against Streptococcus pneumoniae isolate 1394 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46392,,,5142076,[],CHEMBL1666230,Antimicrobial activity against Streptococcus pneumoniae isolate 1397 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46393,,,5142091,[],CHEMBL1666231,Antimicrobial activity against Streptococcus pneumoniae isolate 1424 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46394,,,5142106,[],CHEMBL1666232,Antimicrobial activity against Streptococcus pneumoniae isolate 1564 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46395,,,5142121,[],CHEMBL1666233,Antimicrobial activity against Streptococcus pneumoniae isolate 2617 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46396,,,5142136,[],CHEMBL1666234,Antimicrobial activity against Streptococcus pneumoniae isolate 2686 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46397,,,5142151,[],CHEMBL1666235,Antimicrobial activity against Streptococcus pneumoniae isolate 2688 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46398,,,5142166,[],CHEMBL1666236,Antimicrobial activity against Streptococcus pneumoniae isolate 2874 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46399,,,5142181,[],CHEMBL1666237,Antimicrobial activity against Streptococcus pneumoniae isolate 2880 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46400,,,5142196,[],CHEMBL1666238,Antimicrobial activity against Streptococcus pneumoniae isolate 3260 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
46401,,,5142211,[],CHEMBL1666240,Antimicrobial activity against Streptococcus pneumoniae isolate 3275 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46402,,,5142226,[],CHEMBL1666241,Antimicrobial activity against Streptococcus pneumoniae isolate 3282 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
46403,,,5142241,[],CHEMBL1666242,Antimicrobial activity against Streptococcus pneumoniae isolate 3346 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
46404,,,5142256,[],CHEMBL1666243,Antimicrobial activity against Streptococcus pneumoniae isolate 3374 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46405,,,5142271,[],CHEMBL1666244,Antimicrobial activity against Streptococcus pneumoniae isolate 3412 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46406,,,5142286,[],CHEMBL1666245,Antimicrobial activity against Streptococcus pneumoniae isolate 3455 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46407,,,5142301,[],CHEMBL1666246,Antimicrobial activity against Streptococcus pneumoniae isolate 3458 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46408,,,5142316,[],CHEMBL1666247,Antimicrobial activity against Streptococcus pneumoniae isolate 3481 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46409,,,5143384,[],CHEMBL1666248,Antimicrobial activity against Streptococcus pneumoniae isolate 3587 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46410,,,5143399,[],CHEMBL1666249,Antimicrobial activity against Streptococcus pneumoniae isolate 3681 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46411,,,5143414,[],CHEMBL1666250,Antimicrobial activity against Streptococcus pneumoniae isolate 3791 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46412,,,5143429,[],CHEMBL1666251,Antimicrobial activity against Streptococcus pneumoniae isolate 4747 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
46413,,,5143444,[],CHEMBL1666252,Antimicrobial activity against Streptococcus pneumoniae isolate 4755 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46414,,,5143472,[],CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46415,,,5143486,[],CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
46416,,,5143500,[],CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46417,,,5143514,[],CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46418,,,5143528,[],CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46419,,,5143542,[],CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46420,,,5143561,[],CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46421,,,5143575,[],CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46422,,,5143622,[],CHEMBL1666084,Antimicrobial activity against Streptococcus pneumoniae isolate 1146 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
46423,,,5143623,[],CHEMBL1666227,Antimicrobial activity against Streptococcus pneumoniae isolate 1147 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46424,,,5143624,[],CHEMBL1666228,Antimicrobial activity against Streptococcus pneumoniae isolate 1384 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46425,,,5143625,[],CHEMBL1666239,Antimicrobial activity against Streptococcus pneumoniae isolate 3263 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326386,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46426,,,5150480,[],CHEMBL1667326,Antimicrobial activity against Clostridium difficile C253 expressing tcdA and tcdB gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46427,,,5150481,[],CHEMBL1667327,"Antimicrobial activity against Clostridium difficile CD25 expressing tcdA, tcdB gene and GyrB Ser416Ala mutant gene by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46428,,,5150482,[],CHEMBL1667328,Antimicrobial activity against Clostridium difficile A422 expressing tcdA and tcdB gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46429,,,5150483,[],CHEMBL1667329,Antimicrobial activity against Clostridium difficile 630 expressing tcdA and tcdB gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46430,,,5150484,[],CHEMBL1667330,Antimicrobial activity against Clostridium difficile BI2 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46431,,,5150485,[],CHEMBL1667334,Antimicrobial activity against Clostridium difficile C253a selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46432,,,5150486,[],CHEMBL1667335,Antimicrobial activity against Clostridium difficile C253b selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46433,,,5150487,[],CHEMBL1667336,Antimicrobial activity against Clostridium difficile C253c selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46434,,,5150488,[],CHEMBL1667461,Antimicrobial activity against Clostridium difficile C253d selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46435,,,5150489,[],CHEMBL1667462,Antimicrobial activity against Clostridium difficile C253e selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46436,,,5150490,[],CHEMBL1667463,Antimicrobial activity against Clostridium difficile C253f selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46437,,,5150491,[],CHEMBL1667467,Antimicrobial activity against Clostridium difficile C253g harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
46438,,,5150492,[],CHEMBL1667468,Antimicrobial activity against Clostridium difficile C253h harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
46439,,,5150493,[],CHEMBL1667469,Antimicrobial activity against Clostridium difficile C253i harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
46440,,,5150494,[],CHEMBL1667473,Antimicrobial activity against Clostridium difficile CD5a harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46441,,,5150495,[],CHEMBL1667474,Antimicrobial activity against Clostridium difficile CD5b harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46442,,,5150496,[],CHEMBL1667475,Antimicrobial activity against Clostridium difficile CD5c harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46443,,,5150497,[],CHEMBL1667479,Antimicrobial activity against Clostridium difficile CD5d harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46444,,,5150498,[],CHEMBL1667480,Antimicrobial activity against Clostridium difficile CD5e harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46445,,,5150499,[],CHEMBL1667481,Antimicrobial activity against Clostridium difficile CD5f harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46446,,,5150500,[],CHEMBL1667485,Antimicrobial activity against Clostridium difficile CD5 1-g harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.0
46447,,,5150501,[],CHEMBL1667486,Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.0
46448,,,5150502,[],CHEMBL1667487,Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.0
46449,,,5150503,[],CHEMBL1667491,"Antimicrobial activity against Clostridium difficile CD5 2-g harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
46450,,,5150504,[],CHEMBL1667492,"Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant gene selected after 8 ug/ml of moxifloxacin by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
46451,,,5150505,[],CHEMBL1667493,"Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
46452,,,5150506,[],CHEMBL1667497,Antimicrobial activity against Clostridium difficile A422a selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46453,,,5150507,[],CHEMBL1667625,Antimicrobial activity against Clostridium difficile A422b selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46454,,,5150508,[],CHEMBL1667626,Antimicrobial activity against Clostridium difficile A422c selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46455,,,5150509,[],CHEMBL1667630,Antimicrobial activity against Clostridium difficile A422d selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46456,,,5150510,[],CHEMBL1667631,Antimicrobial activity against Clostridium difficile A422e selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46457,,,5150511,[],CHEMBL1667632,Antimicrobial activity against Clostridium difficile A422f selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46458,,,5150512,[],CHEMBL1665594,Antimicrobial activity against Clostridium difficile A422g harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46459,,,5150513,[],CHEMBL1665595,Antimicrobial activity against Clostridium difficile A422h harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46460,,,5150514,[],CHEMBL1665596,Antimicrobial activity against Clostridium difficile A422i harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46461,,,5150515,[],CHEMBL1665600,Antimicrobial activity against Clostridium difficile 630a selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46462,,,5150516,[],CHEMBL1665601,Antimicrobial activity against Clostridium difficile 630b selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46463,,,5150517,[],CHEMBL1665602,Antimicrobial activity against Clostridium difficile 630c selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46464,,,5150518,[],CHEMBL1665606,Antimicrobial activity against Clostridium difficile 630d selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46465,,,5150519,[],CHEMBL1665607,Antimicrobial activity against Clostridium difficile 630e selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46466,,,5150520,[],CHEMBL1665608,Antimicrobial activity against Clostridium difficile 630f selected after 4 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46467,,,5150521,[],CHEMBL1665612,Antimicrobial activity against Clostridium difficile 630g harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46468,,,5150522,[],CHEMBL1665613,Antimicrobial activity against Clostridium difficile 630h harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46469,,,5150523,[],CHEMBL1665614,Antimicrobial activity against Clostridium difficile 630i harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46470,,,5150524,[],CHEMBL1665618,Antimicrobial activity against Clostridium difficile BI2a harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46471,,,5150525,[],CHEMBL1665619,Antimicrobial activity against Clostridium difficile BI2b harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46472,,,5150526,[],CHEMBL1665620,Antimicrobial activity against Clostridium difficile BI2c harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.5
46473,,,5150527,[],CHEMBL1665757,Antimicrobial activity against Clostridium difficile BI2d harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,6.0
46474,,,5150528,[],CHEMBL1665758,Antimicrobial activity against Clostridium difficile BI2e harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,6.0
46475,,,5150529,[],CHEMBL1665759,Antimicrobial activity against Clostridium difficile BI2f harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,6.0
46476,,,5150530,[],CHEMBL1665763,Antimicrobial activity against Clostridium difficile C253A selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46477,,,5150531,[],CHEMBL1665764,Antimicrobial activity against Clostridium difficile C253B selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46478,,,5150532,[],CHEMBL1665765,Antimicrobial activity against Clostridium difficile C253C selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46479,,,5150533,[],CHEMBL1665769,Antimicrobial activity against Clostridium difficile C253D selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46480,,,5150534,[],CHEMBL1665770,Antimicrobial activity against Clostridium difficile C253E selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46481,,,5150535,[],CHEMBL1665771,Antimicrobial activity against Clostridium difficile C253F selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46482,,,5150536,[],CHEMBL1665775,Antimicrobial activity against Clostridium difficile CD5A harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46483,,,5150537,[],CHEMBL1665776,Antimicrobial activity against Clostridium difficile CD5B harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46484,,,5150538,[],CHEMBL1665777,Antimicrobial activity against Clostridium difficile CD5C harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.5
46485,,,5150539,[],CHEMBL1665781,Antimicrobial activity against Clostridium difficile CD5D harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46486,,,5150540,[],CHEMBL1665782,Antimicrobial activity against Clostridium difficile CD5E harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46487,,,5150541,[],CHEMBL1665783,Antimicrobial activity against Clostridium difficile CD5F harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46488,,,5150542,[],CHEMBL1666645,Antimicrobial activity against Clostridium difficile A422A selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46489,,,5150543,[],CHEMBL1666646,Antimicrobial activity against Clostridium difficile A422B selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46490,,,5150544,[],CHEMBL1666647,Antimicrobial activity against Clostridium difficile A422C selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
46491,,,5150545,[],CHEMBL1666651,Antimicrobial activity against Clostridium difficile A422D harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46492,,,5150546,[],CHEMBL1666652,Antimicrobial activity against Clostridium difficile A422E harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46493,,,5150547,[],CHEMBL1666653,Antimicrobial activity against Clostridium difficile A422F harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46494,,,5150548,[],CHEMBL1666657,Antimicrobial activity against Clostridium difficile A422G harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46495,,,5150549,[],CHEMBL1666658,Antimicrobial activity against Clostridium difficile A422H harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46496,,,5150550,[],CHEMBL1666659,Antimicrobial activity against Clostridium difficile A422I harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46497,,,5150551,[],CHEMBL1666663,Antimicrobial activity against Clostridium difficile 630A selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46498,,,5150552,[],CHEMBL1666664,Antimicrobial activity against Clostridium difficile 630B selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46499,,,5150553,[],CHEMBL1666665,Antimicrobial activity against Clostridium difficile 630C selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.75
46500,,,5150554,[],CHEMBL1666669,Antimicrobial activity against Clostridium difficile 630D harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.0
46501,,,5150555,[],CHEMBL1666670,Antimicrobial activity against Clostridium difficile 630E harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.0
46502,,,5150556,[],CHEMBL1666671,Antimicrobial activity against Clostridium difficile 630F harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.0
46503,,,5150557,[],CHEMBL1666675,Antimicrobial activity against Clostridium difficile BI2A selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46504,,,5150558,[],CHEMBL1666676,Antimicrobial activity against Clostridium difficile BI2B selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46505,,,5150559,[],CHEMBL1666677,Antimicrobial activity against Clostridium difficile BI2C selected after 4 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
46506,,,5150560,[],CHEMBL1666681,Antimicrobial activity against Clostridium difficile BI2D harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46507,,,5150561,[],CHEMBL1666682,Antimicrobial activity against Clostridium difficile BI2E harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46508,,,5150562,[],CHEMBL1666820,Antimicrobial activity against Clostridium difficile BI2F harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326705,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
46509,,,5154307,[],CHEMBL1661955,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 400 mg, po QD for 7 days",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1325733,=,1,0,=,,Activity,%,,84.4,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,%,UO_0000187,,84.4
46510,,,5154308,[],CHEMBL1661956,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 1 g, po BID for 7 days",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1325733,=,1,0,=,,Activity,%,,84.4,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,%,UO_0000187,,84.4
46511,,,5154318,[],CHEMBL1661952,Antibacterial activity against Helicobacter pylori harboring gyrA mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325733,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,1.0
46512,,,5154319,[],CHEMBL1661953,Antibacterial activity against Helicobacter pylori harboring gyrA mutant gene assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1325733,=,1,0,=,,Activity,%,,47.9,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,%,UO_0000187,,47.9
46513,,,5154322,[],CHEMBL1662074,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 20 mg, po BID for 7 days",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1325733,=,1,0,=,,Activity,%,,84.4,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,%,UO_0000187,,84.4
46514,,,5154323,[],CHEMBL1662076,Antibacterial activity against Helicobacter pylori harboring gyrA mutant gene infected in human assessed as bacterial eradication rate after 7 days,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1325733,=,1,0,=,,Activity,%,,33.3,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,%,UO_0000187,,33.3
46515,,,5154325,[],CHEMBL1661954,Antibacterial activity against Helicobacter pylori harboring gyrA mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325733,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,0.5
46516,,,5154326,[],CHEMBL1661954,Antibacterial activity against Helicobacter pylori harboring gyrA mutant gene by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325733,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC50,mg/L,UO_0000274,,2.0
46517,,,5154327,[],CHEMBL1661954,Antibacterial activity against Helicobacter pylori harboring gyrA mutant gene by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325733,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46518,,,5162748,[],CHEMBL1665066,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
46519,,,5162749,[],CHEMBL1665067,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
46520,,,5162750,[],CHEMBL1665784,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46521,,,5162751,[],CHEMBL1665785,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
46522,,,5162752,[],CHEMBL1665786,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
46523,,,5162753,[],CHEMBL1665787,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46524,,,5162754,[],CHEMBL1665788,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46525,,,5162755,[],CHEMBL1665789,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
46526,,,5162794,[],CHEMBL1665931,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,0.5
46527,,,5162795,[],CHEMBL1665932,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,0.5
46528,,,5162796,[],CHEMBL1665933,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
46529,,,5162797,[],CHEMBL1665934,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
46530,,,5162798,[],CHEMBL1665935,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
46531,,,5162799,[],CHEMBL1665936,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
46532,,,5162800,[],CHEMBL1665937,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,16.0
46533,,,5162801,[],CHEMBL1665938,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327009,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,16.0
46534,,,5163763,[],CHEMBL1654045,Antibacterial activity against quinolone-susceptible Bordetella pertussis CCUG 30837 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
46535,,,5163764,[],CHEMBL1654046,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP101 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
46536,,,5163765,[],CHEMBL1654047,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP106 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.004
46537,,,5163766,[],CHEMBL1654048,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP109 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.004
46538,,,5163767,[],CHEMBL1654049,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP111 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
46539,,,5163768,[],CHEMBL1654050,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP112 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.004
46540,,,5163769,[],CHEMBL1654051,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP113 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.004
46541,,,5163770,[],CHEMBL1654052,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP115 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
46542,,,5163771,[],CHEMBL1654053,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP128 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
46543,,,5163772,[],CHEMBL1654054,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP58 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.032
46544,,,5163773,[],CHEMBL1654055,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP99 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.032
46545,,,5163774,[],CHEMBL1654056,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP117 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.032
46546,,,5163775,[],CHEMBL1654057,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP118 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.032
46547,,,5163776,[],CHEMBL1654058,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP121 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.032
46548,,,5163777,[],CHEMBL1654059,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP122 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326830,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.032
46549,,,5166289,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
46550,,,5166297,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46551,,,5166301,[],CHEMBL1667173,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,94.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.7
46552,,,5166313,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
46553,,,5166402,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
46554,,,5166414,[],CHEMBL1667174,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,54.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,54.5
46555,,,5166418,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
46556,,,5166426,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
46557,,,5166434,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
46558,,,5166446,[],CHEMBL1667175,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,88.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,88.9
46559,,,5166450,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46560,,Not Active,5166458,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,MIC90,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,,,,
46561,,,5166466,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
46562,,,5166474,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.03
46563,,,5166482,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.03
46564,,,5166490,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC,ug ml-1,UO_0000274,,0.03
46565,,,5166498,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.03
46566,,,5166506,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC,ug ml-1,UO_0000274,,0.03
46567,,,5167560,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,1.0
46568,,,5167568,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,2.0
46569,,,5167576,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,1.0
46570,,,5167584,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC50,ug ml-1,UO_0000274,,0.12
46571,,,5167592,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.12
46572,,,5167600,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC50,ug ml-1,UO_0000274,,0.12
46573,,Not Active,5167608,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,MIC90,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,,,,
46574,,,5167616,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,8.0
46575,,,5167624,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46576,,,5167632,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC90,ug ml-1,UO_0000274,,2.0
46577,,,5167640,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,0.25
46578,,,5167648,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46579,,,5167660,[],CHEMBL1667176,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,83.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,83.3
46580,,,5167668,[],CHEMBL1667177,Antibacterial activity against Staphylococcus haemolyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,64.4,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,64.4
46581,,,5167676,[],CHEMBL1667178,Antibacterial activity against Staphylococcus hominis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,32.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,32.0
46582,,,5167684,[],CHEMBL1667179,Antibacterial activity against Staphylococcus lugdunensis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,60.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,60.0
46583,,,5167692,[],CHEMBL1667180,Antibacterial activity against Staphylococcus saprophyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,99.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,Activity,%,UO_0000187,,99.0
46584,,,5167700,[],CHEMBL1667181,Antibacterial activity against Staphylococcus warneri assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,86.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,Activity,%,UO_0000187,,86.0
46585,,,5167709,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.015
46586,,,5167717,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
46587,,,5167725,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC,ug ml-1,UO_0000274,,0.015
46588,,,5167733,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
46589,,,5167741,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.03
46590,,,5167749,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC50,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.015
46591,,,5167757,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC50,ug.mL-1,,0.015,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,0.015
46592,,,5167765,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC50,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.015
46593,,,5167773,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.06
46594,,,5167781,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
46595,,,5167789,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,0.06
46596,,,5167797,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
46597,,,5167805,[],CHEMBL1667182,Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,100.0
46598,,,5167813,[],CHEMBL1667183,Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
46599,,,5167821,[],CHEMBL1667184,Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,100.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,Activity,%,UO_0000187,,100.0
46600,,,5167829,[],CHEMBL1667185,Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
46601,,,5167888,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
46602,,,5167896,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
46603,,,5168993,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,0.015
46604,,,5169001,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC,ug ml-1,UO_0000274,,0.015
46605,,,5169009,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC,ug ml-1,UO_0000274,,0.015
46606,,,5169017,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.015
46607,,,5169025,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,0.015
46608,,,5169033,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC,ug ml-1,UO_0000274,,0.015
46609,,,5169041,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,0.015
46610,,,5169049,[],CHEMBL1667188,Antibacterial activity against Streptococcus pyogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,<=,1,0,<=,,Activity,%,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.015
46611,,Not Active,5169057,[],CHEMBL1667189,Antibacterial activity against Streptococcus anginosus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
46612,,Not Active,5169065,[],CHEMBL1667190,Antibacterial activity against Streptococcus bovis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,Activity,,,,
46613,,Not Active,5169073,[],CHEMBL1667191,Antibacterial activity against Streptococcus constellatus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,Activity,,,,
46614,,Not Active,5169081,[],CHEMBL1667192,Antibacterial activity against Streptococcus intermedius assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,Activity,,,,
46615,,Not Active,5169089,[],CHEMBL1667193,Antibacterial activity against Streptococcus mitis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,Activity,,,,
46616,,Not Active,5169097,[],CHEMBL1667194,Antibacterial activity against Streptococcus oralis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,Activity,,,,
46617,,Not Active,5169105,[],CHEMBL1667195,Antibacterial activity against Streptococcus salivarius assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,Activity,,,,
46618,,Not Active,5169113,[],CHEMBL1667196,Antibacterial activity against Streptococcus sanguinis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,Activity,,,,
46619,,,5169116,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.12
46620,,,5169124,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.25
46621,,,5169137,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46622,,,5169145,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46623,,,5169153,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46624,,,5169161,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46625,,,5169169,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46626,,,5169177,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46627,,,5169185,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC50,ug ml-1,UO_0000274,,0.06
46628,,,5169188,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
46629,,,5169196,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
46630,,,5169209,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46631,,,5169217,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46632,,,5169225,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46633,,,5169233,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46634,,,5169241,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46635,,,5169249,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46636,,,5169257,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46637,,,5170417,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC,ug ml-1,UO_0000274,,0.008
46638,,,5170429,[],CHEMBL1667201,Antibacterial activity against Citrobacter koseri assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,99.0,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,Activity,%,UO_0000187,,99.0
46639,,,5170433,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC50,ug ml-1,UO_0000274,,0.015
46640,,,5170441,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC90,ug ml-1,UO_0000274,,0.12
46641,,,5170562,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.015
46642,,,5170574,[],CHEMBL1667206,Antibacterial activity against Klebsiella oxytoca assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,96.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,96.0
46643,,,5170578,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC50,ug ml-1,UO_0000274,,0.03
46644,,,5170586,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46645,,,5170626,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC,ug ml-1,UO_0000274,,0.25
46646,,,5170633,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.03
46647,,Not Active,5170641,[],CHEMBL1667208,Antibacterial activity against Legionella pneumophila assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,Activity,,,,
46648,,Not Active,5170648,[],CHEMBL1667209,Antibacterial activity against Moraxella catarrhalis assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,,,,
46649,,,5170656,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC50,ug ml-1,UO_0000274,,1.0
46650,,,5170663,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.25
46651,,,5170671,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC90,ug ml-1,UO_0000274,,2.0
46652,,,5170678,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.25
46653,,,5170682,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
46654,,,5170694,[],CHEMBL1667210,Antibacterial activity against Morganella morganii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1321813,=,1,0,=,,Activity,%,,90.2,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,%,UO_0000187,,90.2
46655,,,5170698,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC50,ug ml-1,UO_0000274,,0.12
46656,,,5171748,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,8.0
46657,,,5171975,[],CHEMBL1667017,Antibacterial activity against Bacteroides fragilis by CLSI M11-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,1.0
46658,,,5171980,[],CHEMBL1667018,Antibacterial activity against Clostridium perfringens by CLSI M11-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.5
46659,,,5171985,[],CHEMBL1667019,Antibacterial activity against Fusobacterium sp. by CLSI M11-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,,MIC,ug ml-1,UO_0000274,,0.5
46660,,,5171990,[],CHEMBL1667020,Antibacterial activity against Peptostreptococcus sp. by CLSI M11-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,MIC,ug ml-1,UO_0000274,,0.5
46661,,,5171995,[],CHEMBL1667021,Antibacterial activity against Prevotella sp. by CLSI M11-A7 method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
46662,,,5172000,[],CHEMBL1667022,Antibacterial activity against Propionibacterium acnes by CLSI M11-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.25
46663,,Not Active,5172005,[],CHEMBL1667023,Antibacterial activity against Bacteroides fragilis assessed as percent susceptible isolates by CLSI M11-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,Activity,,,,
46664,,Not Active,5172010,[],CHEMBL1667024,Antibacterial activity against Clostridium perfringens assessed as percent susceptible isolates by CLSI M11-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,Activity,,,,
46665,,Not Active,5172015,[],CHEMBL1667166,Antibacterial activity against Fusobacterium sp. assessed as percent susceptible isolates by CLSI M11-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,,Activity,,,,
46666,,Not Active,5172020,[],CHEMBL1667167,Antibacterial activity against Peptostreptococcus sp. assessed as percent susceptible isolates by CLSI M11-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,Activity,,,,
46667,,Not Active,5172025,[],CHEMBL1667168,Antibacterial activity against Prevotella sp. assessed as percent susceptible isolates by CLSI M11-A7 method,F,,,BAO_0000375,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
46668,,Not Active,5172030,[],CHEMBL1667169,Antibacterial activity against Propionibacterium acnes assessed as percent susceptible isolates by CLSI M11-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1321813,,1,0,,,Activity,,,,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,Activity,,,,
46669,,,5172035,[],CHEMBL1667017,Antibacterial activity against Bacteroides fragilis by CLSI M11-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,2.0
46670,,,5172040,[],CHEMBL1667018,Antibacterial activity against Clostridium perfringens by CLSI M11-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC50,ug ml-1,UO_0000274,,1.0
46671,,,5172045,[],CHEMBL1667019,Antibacterial activity against Fusobacterium sp. by CLSI M11-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,,MIC50,ug ml-1,UO_0000274,,1.0
46672,,,5172050,[],CHEMBL1667020,Antibacterial activity against Peptostreptococcus sp. by CLSI M11-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,MIC50,ug ml-1,UO_0000274,,2.0
46673,,,5172055,[],CHEMBL1667021,Antibacterial activity against Prevotella sp. by CLSI M11-A7 method,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,8.0
46674,,,5172060,[],CHEMBL1667022,Antibacterial activity against Propionibacterium acnes by CLSI M11-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC50,ug ml-1,UO_0000274,,0.25
46675,,,5172065,[],CHEMBL1667017,Antibacterial activity against Bacteroides fragilis by CLSI M11-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46676,,,5172070,[],CHEMBL1667018,Antibacterial activity against Clostridium perfringens by CLSI M11-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,ug ml-1,UO_0000274,,1.0
46677,,,5172075,[],CHEMBL1667019,Antibacterial activity against Fusobacterium sp. by CLSI M11-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46678,,,5172080,[],CHEMBL1667020,Antibacterial activity against Peptostreptococcus sp. by CLSI M11-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,MIC90,ug ml-1,UO_0000274,,4.0
46679,,,5172085,[],CHEMBL1667021,Antibacterial activity against Prevotella sp. by CLSI M11-A7 method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
46680,,,5173110,[],CHEMBL1667022,Antibacterial activity against Propionibacterium acnes by CLSI M11-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321813,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46681,,,5173630,[],CHEMBL1654669,Antimycobacterial activity against Mycobacterium tuberculosis 00-0715 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46682,,,5173631,[],CHEMBL1654670,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 03-0738 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
46683,,,5173632,[],CHEMBL1654671,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2934 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
46684,,,5173633,[],CHEMBL1654672,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-1647 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46685,,,5173634,[],CHEMBL1654673,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0930 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46686,,,5173635,[],CHEMBL1654674,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0757 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46687,,,5173636,[],CHEMBL1652928,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0785 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46688,,,5173637,[],CHEMBL1652929,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0790 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46689,,,5173638,[],CHEMBL1652930,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0791 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
46690,,,5173639,[],CHEMBL1652931,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0797 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46691,,,5173640,[],CHEMBL1652932,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 99-1914 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46692,,,5173641,[],CHEMBL1652933,Antimycobacterial activity against Mycobacterium tuberculosis 02-1975 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46693,,,5173642,[],CHEMBL1652934,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2614 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46694,,,5173643,[],CHEMBL1652935,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2230 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46695,,,5173644,[],CHEMBL1652936,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0744 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46696,,,5173645,[],CHEMBL1652937,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0810 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46697,,,5173646,[],CHEMBL1652938,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0821 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46698,,,5173647,[],CHEMBL1652939,Antimycobacterial activity against Mycobacterium tuberculosis 04-0649 harboring gyrA Asp94Asn mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46699,,,5173648,[],CHEMBL1652940,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2399 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
46700,,,5173649,[],CHEMBL1652941,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-0319 harboring gyrA Asp94Ala mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
46701,,,5173650,[],CHEMBL1652942,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0172 harboring gyrA Asp94Ala mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.25
46702,,,5173651,[],CHEMBL1652943,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 04-0519 harboring gyrA Ala90Val and Asp94Asn mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,4.0
46703,,,5173652,[],CHEMBL1652944,Antimycobacterial activity against Mycobacterium tuberculosis 08-0787 harboring gyrA Asp94His mutant gene and deletion of codons 678 and 679 in gyrB mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46704,,,5173653,[],CHEMBL1652945,Antimycobacterial activity against Mycobacterium tuberculosis 08-0745 harboring gyrA Asp89Asn mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
46705,,,5173654,[],CHEMBL1652946,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-1234 harboring gyrA Asn533Thr gyrB mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46706,,,5173655,[],CHEMBL1652947,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2834 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
46707,,,5173656,[],CHEMBL1652948,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0794 harboring gyrA Thr80Ala mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46708,,,5173657,[],CHEMBL1652949,Antimycobacterial activity against Mycobacterium tuberculosis 08-0815 harboring gyrA Thr80Ala and Ala90Gly mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46709,,,5173658,[],CHEMBL1652950,Antimycobacterial activity against Mycobacterium tuberculosis 08-0773 harboring gyrA Pro8Ala mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46710,,,5173659,[],CHEMBL1652951,Antimycobacterial activity against Mycobacterium tuberculosis 08-0769 harboring gyrA putative promoter mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.125
46711,,,5173660,[],CHEMBL1652952,Antimycobacterial activity against Mycobacterium tuberculosis 08-0771 harboring gyrA putative promoter mutant gene by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.125
46712,,,5173661,[],CHEMBL1653052,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0746 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46713,,,5173662,[],CHEMBL1653053,Antimycobacterial activity against Mycobacterium tuberculosis 08-0762 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46714,,,5173663,[],CHEMBL1653054,Antimycobacterial activity against Mycobacterium tuberculosis 08-0764 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46715,,,5173664,[],CHEMBL1653055,Antimycobacterial activity against Mycobacterium tuberculosis 08-0774 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46716,,,5173665,[],CHEMBL1653056,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0777 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46717,,,5173666,[],CHEMBL1653057,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0779 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46718,,,5173667,[],CHEMBL1653058,Antimycobacterial activity against Mycobacterium tuberculosis 08-0781 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46719,,,5173668,[],CHEMBL1653059,Antimycobacterial activity against Mycobacterium tuberculosis 08-0782 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.125
46720,,,5173669,[],CHEMBL1653060,Antimycobacterial activity against Mycobacterium tuberculosis 08-0789 by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322464,<=,1,1,<=,,MIC,ug.mL-1,,0.062,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.062
46721,,Not Active,5173670,[],CHEMBL1653061,Antimycobacterial activity against Mycobacterium tuberculosis 00-0715 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46722,,Not Active,5173671,[],CHEMBL1653062,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 03-0738 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46723,,Not Active,5173672,[],CHEMBL1653063,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2934 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46724,,Not Active,5173673,[],CHEMBL1653064,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-1647 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46725,,Not Active,5173674,[],CHEMBL1653065,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0930 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46726,,Not Active,5173675,[],CHEMBL1653066,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0757 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46727,,Not Active,5173676,[],CHEMBL1653067,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0785 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46728,,Not Active,5173677,[],CHEMBL1653068,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0790 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46729,,Not Active,5173678,[],CHEMBL1653069,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0791 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46730,,Not Active,5173679,[],CHEMBL1653070,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0797 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46731,,Not Active,5173680,[],CHEMBL1653071,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 99-1914 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46732,,Not Active,5173681,[],CHEMBL1653072,Antimycobacterial activity against Mycobacterium tuberculosis 02-1975 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46733,,Not Active,5173682,[],CHEMBL1653073,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2614 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46734,,Not Active,5173683,[],CHEMBL1653074,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2230 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46735,,Not Active,5173684,[],CHEMBL1653075,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0744 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46736,,Not Active,5173685,[],CHEMBL1653076,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0810 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46737,,Not Active,5173686,[],CHEMBL1653077,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0821 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46738,,Not Active,5173687,[],CHEMBL1653078,Antimycobacterial activity against Mycobacterium tuberculosis 04-0649 harboring gyrA Asp94Asn mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46739,,Not Active,5173688,[],CHEMBL1653079,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2399 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46740,,Not Active,5173689,[],CHEMBL1654163,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-0319 harboring gyrA Asp94Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46741,,Not Active,5173690,[],CHEMBL1654164,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0172 harboring gyrA Asp94Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46742,,Not Active,5173691,[],CHEMBL1654165,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 04-0519 harboring gyrA Ala90Val and Asp94Asn mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46743,,Not Active,5173692,[],CHEMBL1654166,Antimycobacterial activity against Mycobacterium tuberculosis 08-0787 harboring gyrA Asp94His mutant gene assessed as microbial susceptibility and deletion of codons 678 and 679 in gyrB mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46744,,Not Active,5173693,[],CHEMBL1654167,Antimycobacterial activity against Mycobacterium tuberculosis 08-0745 harboring gyrA Asp89Asn mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46745,,Not Active,5173694,[],CHEMBL1654168,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-1234 harboring gyrA Asn533Thr gyrB mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46746,,Not Active,5173695,[],CHEMBL1654169,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2834 by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46747,,Active,5173696,[],CHEMBL1654170,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0794 harboring gyrA Thr80Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46748,,Active,5173697,[],CHEMBL1654171,Antimycobacterial activity against Mycobacterium tuberculosis 08-0815 harboring gyrA Thr80Ala and Ala90Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46749,,Active,5173698,[],CHEMBL1654172,Antimycobacterial activity against Mycobacterium tuberculosis 08-0773 harboring gyrA Pro8Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46750,,Active,5173699,[],CHEMBL1654173,Antimycobacterial activity against Mycobacterium tuberculosis 08-0769 harboring gyrA putative promoter mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46751,,Active,5173700,[],CHEMBL1654174,Antimycobacterial activity against Mycobacterium tuberculosis 08-0771 harboring gyrA putative promoter mutant gene assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46752,,Active,5173701,[],CHEMBL1654175,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0746 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46753,,Active,5173702,[],CHEMBL1654176,Antimycobacterial activity against Mycobacterium tuberculosis 08-0762 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46754,,Active,5173703,[],CHEMBL1654177,Antimycobacterial activity against Mycobacterium tuberculosis 08-0764 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46755,,Active,5173704,[],CHEMBL1654178,Antimycobacterial activity against Mycobacterium tuberculosis 08-0774 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46756,,Active,5173705,[],CHEMBL1654179,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0777 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46757,,Active,5173706,[],CHEMBL1654180,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0779 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46758,,Active,5173707,[],CHEMBL1654181,Antimycobacterial activity against Mycobacterium tuberculosis 08-0781 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46759,,Active,5173708,[],CHEMBL1654182,Antimycobacterial activity against Mycobacterium tuberculosis 08-0782 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46760,,Active,5173709,[],CHEMBL1654183,Antimycobacterial activity against Mycobacterium tuberculosis 08-0789 assessed as microbial susceptibility by agar proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1322464,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
46761,,,5179128,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322827,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.016
46762,,,5179137,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322827,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC50,ug ml-1,UO_0000274,,0.125
46763,,,5179146,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322827,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC90,ug ml-1,UO_0000274,,0.125
46764,,,5179155,[],CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322827,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC,ug ml-1,UO_0000274,,0.016
46765,,,5179162,[],CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322827,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC50,ug ml-1,UO_0000274,,0.125
46766,,,5179169,[],CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322827,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC90,ug ml-1,UO_0000274,,0.125
46767,,,5179194,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46768,,,5179205,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC50,ug.mL-1,,0.00025,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug/L,UO_0000274,,0.25
46769,,,5179216,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC90,ug.mL-1,,0.00025,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug/L,UO_0000274,,0.25
46770,,,5179227,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.063
46771,,,5179238,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC50,ug.mL-1,,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug/L,UO_0000274,,0.5
46772,,,5179249,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC90,ug.mL-1,,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug/L,UO_0000274,,0.5
46773,,,5179260,[],CHEMBL1660034,Antibacterial activity against Mycoplasma genitalium G37 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46774,,,5179271,[],CHEMBL1660035,Antibacterial activity against Mycoplasma genitalium M30 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46775,,,5179282,[],CHEMBL1660036,Antibacterial activity against Mycoplasma genitalium R32 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46776,,,5179293,[],CHEMBL1660037,Antibacterial activity against Mycoplasma genitalium TW10-5G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46777,,,5179304,[],CHEMBL1660038,Antibacterial activity against Mycoplasma genitalium TW10-6G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46778,,,5179315,[],CHEMBL1660039,Antibacterial activity against Mycoplasma genitalium TW48-5G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46779,,,5179326,[],CHEMBL1660040,Antibacterial activity against Mycoplasma genitalium UTMB-10G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
46780,,,5179337,[],CHEMBL1660041,Antibacterial activity against Mycoplasma genitalium M2282 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46781,,,5179348,[],CHEMBL1660042,Antibacterial activity against Mycoplasma genitalium M2300 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46782,,,5179359,[],CHEMBL1660043,Antibacterial activity against Mycoplasma genitalium M2321 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46783,,,5179370,[],CHEMBL1660044,Antibacterial activity against Mycoplasma genitalium M2341 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46784,,,5179381,[],CHEMBL1660045,Antibacterial activity against Mycoplasma genitalium M6257 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46785,,,5179392,[],CHEMBL1660046,Antibacterial activity against Mycoplasma genitalium M6280 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46786,,,5179403,[],CHEMBL1660047,Antibacterial activity against Mycoplasma genitalium M6285 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46787,,,5179414,[],CHEMBL1660048,Antibacterial activity against Mycoplasma genitalium M6286 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46788,,,5179425,[],CHEMBL1660173,Antibacterial activity against Mycoplasma genitalium M6328 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46789,,,5180479,[],CHEMBL1660174,Antibacterial activity against Mycoplasma genitalium M6090 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46790,,,5180490,[],CHEMBL1660175,Antibacterial activity against Mycoplasma genitalium M6151 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46791,,,5180501,[],CHEMBL1660176,Antibacterial activity against Mycoplasma genitalium M6282 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46792,,,5180512,[],CHEMBL1660177,Antibacterial activity against Mycoplasma genitalium M6283 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46793,,,5180523,[],CHEMBL1660178,Antibacterial activity against Mycoplasma genitalium M6284 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46794,,,5180534,[],CHEMBL1660179,Antibacterial activity against Mycoplasma genitalium M6287 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322838,=,1,1,=,,MIC,ug.mL-1,,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.031
46795,,,5215124,[],CHEMBL1676103,Inhibition of human ERG,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671772,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,1,http://www.openphacts.org/units/Nanomolar,1332786,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
46796,,,5229662,[],CHEMBL1678266,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1332115,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
46797,,,5229681,[],CHEMBL1678264,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1332115,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
46798,,,5229692,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332115,<,1,1,<,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
46799,,,5229709,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332115,<,1,1,<,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
46800,,,5229723,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332115,<,1,1,<,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
46801,,,5230320,[],CHEMBL1679680,Antimicrobial activity against Clostridium difficile harboring ribotype 027 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,1.0
46802,,,5230321,[],CHEMBL1679680,Antimicrobial activity against Clostridium difficile harboring ribotype 027 by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,mg/L,UO_0000274,,32.0
46803,,,5230322,[],CHEMBL1679680,Antimicrobial activity against Clostridium difficile harboring ribotype 027 by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,32.0
46804,,,5230323,[],CHEMBL1679681,Antimicrobial activity against Clostridium difficile harboring ribotype 001 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,2.0
46805,,,5230324,[],CHEMBL1679681,Antimicrobial activity against Clostridium difficile harboring ribotype 001 by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,mg/L,UO_0000274,,32.0
46806,,,5230325,[],CHEMBL1679681,Antimicrobial activity against Clostridium difficile harboring ribotype 001 by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,32.0
46807,,,5230326,[],CHEMBL1679682,Antimicrobial activity against Clostridium difficile harboring other ribotypes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,1.0
46808,,,5230327,[],CHEMBL1679682,Antimicrobial activity against Clostridium difficile harboring other ribotypes by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,mg/L,UO_0000274,,2.0
46809,,,5230328,[],CHEMBL1679682,Antimicrobial activity against Clostridium difficile harboring other ribotypes by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331688,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,32.0
46810,,,5296297,[],CHEMBL1691259,Bacteriostatic activity against Escherichia coli K-12 DM4100,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338192,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.04
46811,,,5296312,[],CHEMBL1691260,Bactericidal activity against Escherichia coli K-12 DM4100 after 2 hrs in presence of protein synthesis inhibitor chloramphenicol treated 10 mins before compound challenge,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338192,=,1,0,=,,LD99,ug ml-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,LD99,ug ml-1,UO_0000274,,0.2
46812,,,5296327,[],CHEMBL1691261,Ratio of LD99 for Escherichia coli K-12 DM4100 to MIC for Escherichia coli K-12 DM4100,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1338192,=,1,0,=,,Ratio,,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,5.0
46813,,,5296346,[],CHEMBL1691262,Antibacterial activity against Escherichia coli KAM32 harboring Staphylococcus aureus cloned pSP72 lmrS by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338211,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.08
46814,,,5296363,[],CHEMBL1691263,Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338211,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
46815,,,5296380,[],CHEMBL1691264,Ratio of MIC for Escherichia coli KAM32 harboring cloned pSP72 lmrS to MIC for Escherichia coli KAM32 harboring pSP72,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687808,Antimicrob Agents Chemother,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338211,=,1,1,=,,MIC,ug.mL-1,,4.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.1
46816,,,5303994,[],CHEMBL1695969,"Oral bioavailability in healthy human at 400 mg/kg, po",A,,,BAO_0003042,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1337282,=,1,1,=,,F,%,,96.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,96.0
46817,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5303995,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1695971,"Cmax in patients with pulmonary tuberculosis at 400 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1337282,=,1,1,=,,Cmax,nM,,9057.01,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,mg/L,UO_0000065,,3.4
46818,,,5303996,[],CHEMBL1695972,"Tmax in patients with pulmonary tuberculosis at 400 mg/kg, po",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,1337282,=,1,1,=,,Tmax,hr,,1.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.5
46819,,,5303997,[],CHEMBL1695973,"Half life in patients with pulmonary tuberculosis at 400 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,1337282,=,1,1,=,,T1/2,hr,,6.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.5
46820,,,5303998,[],CHEMBL1695974,"Plasma protein binding in healthy human at 400 mg/kg, po",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1337282,=,1,1,=,,PPB,%,,20.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,20.0
46821,,,5304011,[],CHEMBL1696464,"Renal excretion in healthy human at 400 mg/kg, po administered as single dose",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,1337282,=,1,0,=,,Activity,%,,77.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,77.0
46822,,,5304012,[],CHEMBL1695965,Antimicrobial activity against rifampicin-resistant Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337282,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.2
46823,,WE: Weak evidence (<10 case reports) of human hepatotoxicity,5315980,[],CHEMBL1697722,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697692,Chem Res Toxicol,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1339798,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
46824,,DILI negative (training set),5316636,[],CHEMBL1697730,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697723,Drug Metab Dispos,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1340454,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
46825,,drug-induced liver injury reported,5317415,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1341201,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
46826,,no drug-induced liver injury reported,5318366,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1341201,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
46827,,no drug-induced liver injury reported,5319317,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1341201,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
46828,,inconclusive,5574719,[],CHEMBL1738394,"PUBCHEM_BIOASSAY: Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485290, AID485312, AID504464, AID504474]",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1158129,,7,1,,,Potency,nM,,100000.0,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,100.0
46829,,inconclusive,5979960,[],CHEMBL1613933,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",B,,,BAO_0000186,BAO_0000224,protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1158129,,7,1,,,Potency,nM,,39810.7,CHEMBL2093862,Homo sapiens,Runt-related transcription factor 1/Core-binding factor subunit beta,9606.0,,,Potency,uM,UO_0000065,,39.8107
46830,,,6228615,[],CHEMBL1785786,Cytotoxicity against MDCK cells after 48 hrs by CPE assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1427624,=,1,1,=,,CC50,nM,,396000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,,CC50,uM,UO_0000065,,396.0
46831,,,6229788,[],CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
46832,,,6229789,[],CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
46833,,,6229790,[],CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
46834,,,6229791,[],CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
46835,,,6229792,[],CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
46836,,,6229793,[],CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46837,,,6229794,[],CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
46838,,,6229795,[],CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
46839,,,6229796,[],CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
46840,,,6229797,[],CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
46841,,,6229798,[],CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
46842,,,6229799,[],CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
46843,,,6229800,[],CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
46844,,,6229801,[],CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
46845,,,6229802,[],CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
46846,,,6229803,[],CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427624,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
46847,,,6332472,[],CHEMBL1820556,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
46848,,,6332473,[],CHEMBL1820557,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-1 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
46849,,,6332474,[],CHEMBL1820558,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-1 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
46850,,,6332475,[],CHEMBL1820559,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-4 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
46851,,,6332476,[],CHEMBL1820560,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-3 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
46852,,,6332477,[],CHEMBL1820561,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
46853,,,6332478,[],CHEMBL1820562,Antibacterial activity against Streptococcus pneumoniae 08-2 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
46854,,,6332479,[],CHEMBL1820563,Antibacterial activity against Streptococcus pneumoniae 08-4 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
46855,,,6332480,[],CHEMBL1820564,Antibacterial activity against Enterococcus faecium 08-2 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
46856,,,6332481,[],CHEMBL1820565,Antibacterial activity against Enterococcus faecium 08-7 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
46857,,,6332482,[],CHEMBL1820566,Antibacterial activity against Enterococcus faecalis 08-10 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
46858,,,6332483,[],CHEMBL1820567,Antibacterial activity against Enterococcus faecalis 08-12 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
46859,,,6332484,[],CHEMBL1820568,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
46860,,,6332485,[],CHEMBL1820569,Antibacterial activity against Escherichia coli 08-21 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
46861,,,6332486,[],CHEMBL1820570,Antibacterial activity against Escherichia coli 08-22 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
46862,,,6332487,[],CHEMBL1820571,Antibacterial activity against Klebsiella pneumoniae 09-22 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
46863,,,6332488,[],CHEMBL1820597,Antibacterial activity against Klebsiella pneumoniae 09-23 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
46864,,,6332489,[],CHEMBL1820572,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
46865,,,6332490,[],CHEMBL1820573,Antibacterial activity against Pseudomonas aeruginosa 09-32 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
46866,,,6332491,[],CHEMBL1820574,Antibacterial activity against Pseudomonas aeruginosa 09-33 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
46867,,,6332492,[],CHEMBL1820575,Antibacterial activity against Pseudomonas aeruginosa 09-34 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451021,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
46868,,active,6447344,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1486857,,7,1,,,Potency,nM,,39810.7,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,39.8107
46869,,active,6514896,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1486857,,7,1,,,Potency,nM,,5358.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,5.3582
46870,,inconclusive,6864515,[],CHEMBL1794486,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1491107,,7,1,,,Potency,nM,,39810.7,CHEMBL5027,Homo sapiens,Flap endonuclease 1,9606.0,,,Potency,uM,UO_0000065,,39.8107
46871,,inconclusive,7172264,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1486857,,7,1,,,Potency,nM,,15101.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,15.1014
46872,,inactive,7443588,[],CHEMBL1794440,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1201862,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,1491107,,7,1,,,Potency,nM,,56234.1,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,56.2341
46873,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657550,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,,,,
46874,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657551,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
46875,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657552,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
46876,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657553,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
46877,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657554,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
46878,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657555,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
46879,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657556,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
46880,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657557,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
46881,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657558,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46882,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657559,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46883,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657560,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
46884,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657561,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
46885,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657562,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
46886,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657563,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
46887,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659553,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
46888,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659554,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
46889,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659555,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
46890,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659556,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
46891,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659557,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,,,,
46892,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659558,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,,,,
46893,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659559,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,,,,
46894,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659560,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,,,,
46895,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659561,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
46896,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659562,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
46897,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659563,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
46898,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659564,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
46899,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659565,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
46900,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659566,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
46901,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659567,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
46902,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659568,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
46903,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659569,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
46904,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659570,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
46905,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659571,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
46906,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659572,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
46907,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659573,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46908,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659574,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46909,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659575,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46910,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659576,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46911,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659577,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46912,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659578,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46913,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659579,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
46914,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659580,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
46915,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659581,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
46916,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659582,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
46917,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659583,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46918,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659584,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46919,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659585,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46920,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659586,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46921,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659587,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46922,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659588,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46923,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659589,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
46924,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659590,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
46925,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659591,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
46926,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659592,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
46927,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659593,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
46928,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659594,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
46929,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659595,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
46930,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659596,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
46931,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659597,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
46932,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659598,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
46933,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659599,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
46934,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659600,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
46935,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659601,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
46936,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659602,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
46937,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659603,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
46938,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659604,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
46939,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659605,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
46940,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659606,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
46941,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659607,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
46942,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659608,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
46943,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659609,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
46944,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659610,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
46945,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659611,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
46946,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659612,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
46947,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659613,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
46948,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659614,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
46949,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659615,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
46950,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659616,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
46951,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659617,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,,,,
46952,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659618,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
46953,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659619,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
46954,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659620,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
46955,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659621,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
46956,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659622,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
46957,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659623,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
46958,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659624,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
46959,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659625,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
46960,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659626,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
46961,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659627,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
46962,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659628,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
46963,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659629,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
46964,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659630,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
46965,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659631,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
46966,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659632,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
46967,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659633,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
46968,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659634,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
46969,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659635,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
46970,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659636,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
46971,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659637,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
46972,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659638,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
46973,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659639,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46974,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659640,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46975,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659641,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46976,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659642,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46977,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659643,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46978,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659644,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46979,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659645,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
46980,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659646,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
46981,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659647,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46982,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659648,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46983,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659649,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46984,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659650,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46985,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659651,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46986,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659652,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46987,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659653,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46988,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659654,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46989,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659655,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
46990,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659656,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
46991,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659657,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
46992,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659658,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
46993,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659659,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
46994,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659660,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
46995,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659661,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
46996,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659662,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
46997,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659663,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
46998,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659664,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
46999,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659665,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
